Financial results - GINCO PHARM S.R.L.

Financial Summary - Ginco Pharm S.r.l.
Unique identification code: 18968175
Registration number: J12/2849/2006
Nace: 4773
Sales - Ron
430.743
Net Profit - Ron
7.929
Employees
1
Open Account
Company Ginco Pharm S.r.l. with Fiscal Code 18968175 recorded a turnover of 2024 of 430.743, with a net profit of 7.929 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Ginco Pharm S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 261.432 250.933 277.906 285.508 296.537 337.046 322.084 368.621 411.417 430.743
Total Income - EUR 262.574 261.780 286.829 289.933 300.800 341.538 328.636 373.890 417.189 437.751
Total Expenses - EUR 248.836 241.246 262.127 268.965 283.775 313.650 305.625 355.490 404.694 416.953
Gross Profit/Loss - EUR 13.738 20.534 24.702 20.969 17.025 27.888 23.011 18.400 12.495 20.799
Net Profit/Loss - EUR 11.407 17.170 21.670 18.069 14.015 24.728 20.119 14.736 9.002 7.929
Employees 2 2 2 2 2 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 5.3%, from 411.417 euro in the year 2023, to 430.743 euro in 2024. The Net Profit decreased by -1.022 euro, from 9.002 euro in 2023, to 7.929 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Ginco Pharm S.r.l.

Rating financiar

Financial Rating -
GINCO PHARM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Ginco Pharm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ginco Pharm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Ginco Pharm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ginco Pharm S.r.l. - CUI 18968175

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 22.605 22.375 21.996 21.592 21.174 21.289 20.608 20.463 11.034 4.841
Current Assets 79.670 59.607 75.407 67.242 84.733 76.161 88.055 103.865 98.515 105.329
Inventories 38.296 36.115 35.026 35.274 38.849 35.630 42.825 44.856 49.259 63.290
Receivables 26.059 7.498 30.959 28.488 43.468 36.989 33.497 50.464 34.500 24.538
Cash 15.315 15.994 9.421 3.480 2.416 3.542 11.733 8.545 14.755 17.500
Shareholders Funds 25.638 17.278 22.019 24.642 25.118 27.832 27.158 14.785 10.643 8.505
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 66.317 64.704 75.384 64.193 80.790 69.619 81.505 109.543 98.906 101.665
Income in Advance 10.320 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 105.329 euro in 2024 which includes Inventories of 63.290 euro, Receivables of 24.538 euro and cash availability of 17.500 euro.
The company's Equity was valued at 8.505 euro, while total Liabilities amounted to 101.665 euro. Equity decreased by -2.078 euro, from 10.643 euro in 2023, to 8.505 in 2024.

Risk Reports Prices

Reviews - Ginco Pharm S.r.l.

Comments - Ginco Pharm S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.